4baseCare, An Illumina Accelerator Company, is engaged in the development of cutting-edge precision oncology solutions, using advanced genomics and next-gen digital health technology, to personalise patient care in oncology. They have developed a unique set of comprehensive genomic panels which allows oncologists to choose the optimal targeted therapy for their patients.
4baseCare, a precision oncology company in India, launched their product - TARGT Indiegene, India’s largest and first population-specific tumour gene panel derived from Whole Exome and Whole Transcriptome data of over 1500 cancer patients across 28 different cancer types. Most of the patients... (more)
